CSGP vs OGEN · P/E 484, rev $2.74B vs rev $37.7K
CoStar Group Inc (CSGP) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the CSGP and OGEN stock pages for the full models.
Not investment advice.